Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
about
An orally delivered small-molecule formulation with antiangiogenic and anticancer activityLinking form to function: Biophysical aspects of artificial antigen presenting cell designGold nanoparticles for cancer radiotherapy: a reviewBroad spectrum antiangiogenic treatment for ocular neovascular diseasesAdvances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyDoxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.Stimuli-Responsive Materials for Controlled Release of Theranostic Agents.Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements.Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomasA novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery.Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.PSMA-targeted theranostic nanoplex for prostate cancer therapy.Dual-pH Sensitive Charge-reversal Nanocomplex for Tumor-targeted Drug Delivery with Enhanced Anticancer ActivityHigh efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammationNanoscale artificial antigen presenting cells for T cell immunotherapyThe influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imagingUnraveling the mysteries of serum albumin-more than just a serum protein.Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity.5-Fluorouracil derivatives: a patent review.The duality of oncomiR addiction in the maintenance and treatment of cancer.Polyethylene glycol-modified dendrimer-entrapped gold nanoparticles enhance CT imaging of blood pool in atherosclerotic mice.Significance and applications of nanoparticles in siRNA delivery for cancer therapy.Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapyHyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma.Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluationCo-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapy.A HPLC method for the quantitative determination of N-(2-hydroxy-5-nitrophenylcarbamothioyl)-3,5-dimethylbenzamide in biological samples.Nanoparticles for biomedical imagingIn vivo enhancement of anticancer therapy using bare or chemotherapeutic drug-bearing nanodiamond particles.Biodegradable Polymers Induce CD54 on THP-1 Cells in Skin Sensitization TestPreparation of poly(β-L-malic acid)-based charge-conversional nanoconjugates for tumor-specific uptake and cellular deliverySynthesis and evaluation of poly(styrene-co-maleic acid) micellar nanocarriers for the delivery of tanespimycin.The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency.
P2860
Q24649290-6B8E1ED4-6E79-4146-9624-2F0990D6D5B5Q27002652-292D01CF-B57D-476E-B747-AA5555A87823Q28066413-DBE01877-5208-4B01-84F5-28877EFF3C08Q28475373-BD94A8D1-98E4-4C04-8C77-2A34FD4EA255Q28829239-943C31FF-0402-4093-8092-FBC7C9E289B5Q30375538-75B207FE-04AB-4E86-ADBF-5AF66AB66777Q30406730-B73AB311-8D20-4DF1-9CC8-E71A8853186DQ30421668-2A5DA54C-3D81-4426-B512-C93ED7CCED97Q30478123-EC8BFDCD-7219-4445-BEAE-2C8061E1B512Q30539275-99E2F658-0843-470F-8FD4-21D5037E939FQ31144211-5AA627B0-8F23-4F1E-AF0C-78A4A762959FQ33405612-62018236-0F9F-4E8E-8719-44E56291D593Q33564844-EB387AE6-F645-4EAA-BDE5-90DD7473CEC0Q33676634-28F6FEBD-15F3-4768-B320-83151F254703Q33691051-C9EA7BC6-212D-4153-AC12-24707802C9ACQ33791366-79F739F8-338E-4EB7-9E8C-990304100901Q33820964-3A6983BD-892B-4043-9365-8B4CDFDC2CDFQ33828697-23254720-9B4B-45E2-8648-BE267BF2C858Q33968244-55C5035F-7090-48FD-8381-924B0525961CQ33968408-CA181A50-E6B5-4383-B19A-712ABF950619Q33981400-D59F2AD0-B470-4FDA-9019-E6BA01190478Q34030577-7B11EA19-E87A-4E36-A8F6-B628D9127398Q34153916-4FA31FE2-3C16-4A9A-8F11-16DBD19F8581Q34253978-9BD6DC40-55A0-4D36-A4E2-00E4A4AB908CQ34278112-B0189090-BE07-499E-918A-0E19911413EEQ34287591-020BC685-9AFC-4033-9E70-365B440CF6DDQ34297263-BFA1EA5C-A28A-4D90-95A2-606BD713E00EQ34348175-A6044488-04DC-40D7-8F11-1300FE20082EQ34377387-51021C76-2156-4A73-AA9D-F14588428FD6Q34396694-26455BAF-07AD-435E-831B-ADCA50551526Q34478394-3BA19C70-3BE0-4DF6-8352-7CD000CDF4ADQ34599354-40C12E52-65D4-405B-9142-A8527E1E5701Q34984769-4C735714-C6F3-41B0-BE6E-542896AED708Q34988900-3EC75FCD-4088-45B7-A9D3-5F62B81B58B5Q34989401-B91A8546-38CC-40A0-A0CD-94A73E8A088AQ35109951-F799C98A-D28C-4E22-AC6D-00D9B6BA9A64Q35149078-2FE0DE10-4BE9-435A-BC73-9BDFF992E45DQ35189737-C5612AEC-181D-470B-9917-DC101F01031FQ35375097-5EE7E48D-37F9-4107-9780-EBBF1114B4ECQ35411243-5E09D1BE-6240-4297-9557-9CD5989B4D39
P2860
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Enhanced permeability and rete ...... eted anticancer nanomedicines.
@en
type
label
Enhanced permeability and rete ...... eted anticancer nanomedicines.
@en
prefLabel
Enhanced permeability and rete ...... eted anticancer nanomedicines.
@en
P2860
P1476
Enhanced permeability and rete ...... geted anticancer nanomedicines
@en
P2093
Khaled Greish
P2860
P304
P356
10.1080/10611860701539584
P577
2007-08-01T00:00:00Z